Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure

Cardiovascular Research

Volumn 46, Issue 1, 2000, Pages 73-81

  Matsumoto, Toshiyuki ^a   Ozono, Ryoji ^a   Oshima, Tetsuya ^a   Matsuura, Hideo ^a   Sueda, Taijiro ^a   Kajiyama, Goro ^a   Kambe, Masayuki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Coronary disease; Fibrosis; Heart failure; Ischemia; Myocytes; Receptors; Ventricular function

Indexed keywords

ANGIOTENSIN RECEPTOR; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034015429     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00008-0     Document Type: Article

References (36)

1. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865.
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med. 316:1987;1429-1435.
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 325:1991;293-302. see comments.
4. Asano K., Dutcher D.L., Port J.D., et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation. 95:1997;1193-1200. See comments. Published erratum appears in Circulation 1997 Dec 16;96(12):4435.
5. Regitz-Zagrosek V., Fielitz J., Dreysse R., Hildebrandt A.G., Fleck E. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovasc Res. 35:1997;99-105.
6. Regitz-Zagrosek V., Friedel N., Heymann A., et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation. 91:1995;1461-1471.
7. Brink M., Erne P., de Gasparo M., et al. Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol. 28:1996;1789-1799.
8. Haywood G.A., Gullestad L., Katsuya T., et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation. 95:1997;1201-1206.
9. Tsutsumi Y., Matsubara H., Ohkubo N., et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res. 83:1998;1035-1046.
10. Wharton J., Morgan K., Rutherford R.A., et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 284:1998;323-336.
11. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res. 73:1993;413-423.
12. Tsuzuki S., Matoba T., Eguchi S., Inagami T. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension. 28:1996;916-918.
13. Stoll M., Steckelings U.M., Paul M., Bottari S.P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 95:1995;651-657.
14. Shanmugam S., Corvol P., Gasc J.M. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension. 28:1996;91-97.
15. Ohkubo N., Matsubara H., Nozawa Y., et al. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 96:1997;3954-3962.
16. Christen Y., Waeber B., Nussberger J., et al. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation. 83:1991;1333-1342.
17. Weber K.T., Anversa P., Armstrong P.W., et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 20:1992;3-16.
18. Ozono R., Wang Z.Q., Moore A.F., Inagami T., Siragy H.M., Carey R.M. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension. 30:1997;1238-1246.
19. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1083.
20. Devereux R.B., Lutas E.M., Casale P.N., et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 4:1984;1222-1230.
21. Koike G., Horiuchi M., Yamada T., Szpirer C., Jacob H.J., Dzau V.J. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun. 203:1994;1842-1850.
22. Servant G., Dudley D.T., Escher E., Guillemette G. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol. 45:1994;1112-1118.
23. Ozono.R, Matsumoto, T, Shingu, T, et al. Expression and localization of angiotensin subtype receptor proteins in the heart of spontaneously hypertensive rats. Am J Physiol 2000 (in press).
24. Wang Z.Q., Moore A.F., Ozono R., Siragy H.M., Carey R.M. Immunolocalization of subtype 2 angiotensis 2 (at2) receptor protein in rat heart. Hypertension. 32:1998;75-83.
25. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
26. Masaki H., Kurihara T., Yamaki A., et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 101:1998;527-535.
27. Liu Y.H., Yang X.P., Sharov V.G., et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest. 99:1997;1926-1935.
28. Kijima K., Matsubara H., Murasawa S., et al. Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension. 27:1996;529-534.
29. Ichiki T., Kambayashi Y., Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Circ Res. 77:1995;1070-1076.
30. Bowling N., Walsh R.A., Song G., et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart [see comments]. Circulation. 99:1999;384-391.
31. Hao J., Ju H., Zhao S., Junaid A., Scammell-La Fleur T., Dixon I.M. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol. 31:1999;667-678.
32. Siemens I.R., Reagan L.P., Yee D.K., Fluharty S.J. Biochemical characterization of two distinct angiotensin AT2 receptor populations in murine neuroblastoma N1E-115 cells. J Neurochem. 62:1994;2106-2115.
33. Nozawa Y., Miyake H., Haruno A., et al. Down-regulation of angiotensin II receptors in hypertrophied human myocardium. Clin Exp Pharmacol Physiol. 23:1996;514-518.
34. Rogg H., de Gasparo M., Graedel E., et al. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction [see comments]. Eur Heart J. 17:1996;1112-1120.
35. Gullestad L., Haywood G., Aass H., et al. Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation. Cardiovasc Res. 38:1998;340-347.
36. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 95:1995;46-54.